The Only Global RAS Dedicated Conference is Returning in 2022 with the 3rd RAS/MAPK Pathway Targeted Drug Discovery Summit! Year on year, we are proud to unite the leading frontiers […]

As the CAR-T field continues to explode with new companies, investment, and clinical collaborations, it's more important than ever to stay ahead of the curve. Stakeholders across oncology are now […]

We are happy to announce that the Mitochondria-Targeted Drug Development Summit, focused on the pursuit for novel effective therapies for mitochondrial disorders/dysfunction, will be delivered in-person, for its 2nd edition. […]